| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +0.54% | -1.16% | +43.97% | +141.80% | 983B | |
| +3.38% | +1.59% | +57.90% | +44.39% | 557B | |
| +1.71% | +5.24% | +27.41% | +72.26% | 406B | |
| +1.53% | -1.93% | +23.33% | +16.35% | 314B | |
| +2.26% | +2.30% | +30.42% | +18.98% | 273B | |
| +2.61% | +3.11% | +29.81% | +36.09% | 272B | |
| +2.60% | +9.79% | -31.71% | -43.45% | 203B | |
| +0.66% | -0.30% | +27.29% | +52.69% | 186B | |
| +0.23% | -1.70% | +17.78% | +61.44% | 155B | |
| Average | +1.66% | -0.92% | +25.13% | +44.51% | 372.26B | |
| Weighted average by Cap. | +1.78% | -2.22% | +33.35% | +66.88% |
Employees
4
Sector
Pharmaceuticals
